microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity
2010 · British Journal of Cancer · 251 citations
https://doi.org/10.1038/sj.bjc.6605895
Y
Yuan Yang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
186
Papers
9.8K
Citations
47
h-index
107
i10-index
Yuan Yang is an academic researcher from Nanjing Tech University. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & RNA modifications and cancer & Cancer-related molecular mechanisms research. The author has an h-index of 47, co-authored 159 publications.
ORCID: 0000-0001-9096-4716Papers by this author
worksGWAS Identifies Novel Susceptibility Loci on 6p21.32 and 21q21.3 for Hepatocellular Carcinoma in Chronic Hepatitis B Virus Carriers
2012 · PLoS Genetics · 204 citations
https://doi.org/10.1371/journal.pgen.1002791
Genomic <i>ERBB2</i> / <i>ERBB3</i> mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis
2018 · Gut · 199 citations
https://doi.org/10.1136/gutjnl-2018-316039
miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy
2019 · Gut · 134 citations
https://doi.org/10.1136/gutjnl-2019-318830
Aldolase B inhibits metastasis through Ten–Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma
2015 · Molecular Cancer · 84 citations
https://doi.org/10.1186/s12943-015-0437-7
TMED3 promotes hepatocellular carcinoma progression via IL-11/STAT3 signaling
2016 · Scientific Reports · 71 citations
https://doi.org/10.1038/srep37070
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat